Bloomberg Law
May 19, 2020, 5:23 PMUpdated: May 19, 2020, 8:38 PM

FDA Teams Up With Data Company Aetion to Study Virus Progression (1)

Jacquie Lee
Jacquie Lee

The FDA said Tuesday it’s pairing up with the data company Aetion to research Covid-19 complications and what types of medicines virus patients are taking, which could help researchers learn more about which treatments are effective.

The Food and Drug Administration is already using its internal drug monitoring system called Sentinel to learn more about Covid-19 responses nationwide. The partnership with Aetion will add to that data to “contribute to the scientific evaluation of potential diagnostics and interventions for COVID-19,” Amy Abernethy, the agency’s principal deputy commissioner of food and drugs, said in a statement.

New cases in hot spots ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.